SpyGlass Pharma, Inc. (SGP) is the 153rd largest of 300 Pharmaceuticals companies by market capitalisation, at 970.92 Mn, behind Lexicon Pharmaceuticals, Inc. at 978.15 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.05 Bn | 31.52 | 6.77 | 642.29 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 452.62 Bn | 71.66 | 7.03 | 446.05 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 371.61 Bn | 117.26 | 5.58 | 364.47 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 309.81 Bn | 13.77 | 4.51 | 302.12 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.46 Bn | 37.19 | 2.55 | 150.76 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.82 Bn | 11.55 | 1.00 | 46.44 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.08 Bn | -24.93 | — | 44.08 Bn |
| 8 | ONC | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 39.98 Bn | 60.98 | 6.52 | 34.89 Bn |
| 9 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.64 Bn | 15.90 | 4.41 | 21.11 Bn |
| 10 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.84 Bn | 15.89 | 6.61 | 18.17 Bn |
| 11 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.71 Bn | 22.27 | 4.66 | 15.32 Bn |
| 12 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.62 Bn | 16.60 | 3.39 | 14.00 Bn |
| 13 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.82 Bn | 17.22 | 6.08 | 13.98 Bn |
| 14 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.79 Bn | 217.59 | 14.20 | 11.49 Bn |
| 15 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.53 Bn | -38.48 | 109.81 | 10.84 Bn |
| 16 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.70 Bn | -69.62 | 13.78 | 10.38 Bn |
| 17 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.28 Bn | -54.61 | — | 10.28 Bn |
| 18 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 19 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.57 Bn | -13.05 | 141.42 | 8.40 Bn |
| 20 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 21 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.75 Bn | 117.19 | 4.65 | 7.09 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.23 Bn | -80.91 | — | 6.23 Bn |
| 23 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.13 Bn | -141.05 | 10.37 | 6.13 Bn |
| 24 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.11 Bn | 44.09 | 13.55 | 5.83 Bn |
| 25 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.69 Bn | -209.73 | 30.55 | 5.37 Bn |
| 26 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.81 Bn | 12.63 | 4.22 | 3.85 Bn |
| 27 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.61 Bn | -23.36 | — | 4.61 Bn |
| 28 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.26 Bn | -12.05 | — | 4.26 Bn |
| 29 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.17 Bn | 11.75 | 3.13 | 3.95 Bn |
| 30 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.99 Bn | -46.30 | — | 3.99 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.94 Bn | -46.85 | — | 3.94 Bn |
| 32 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 33 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.74 Bn | -79.68 | 6.17 | 3.29 Bn |
| 34 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 35 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.13 Bn | -12.07 | 439.70 | 3.13 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.69 Bn | -63.79 | — | 2.69 Bn |
| 37 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | 4.61 | 0.06 | -3.15 Bn |
| 38 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -29.99 | 3.24 | 2.18 Bn |
| 39 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | 13.71 | 2.55 | 1.64 Bn |
| 40 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -22.03 | 14.02 | 2.38 Bn |
| 41 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | -6.77 | — | 2.37 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.24 Bn | -42.17 | — | 1.92 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.69 | 6.75 | 1.66 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | 169.08 | 16.10 | 1.59 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.94 | 3.03 | 0.98 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -24.63 | — | 1.49 Bn |
| 47 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.13 | 4.36 | 1.34 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.51 | 5.16 | 1.34 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | -32.79 | 2.11 | 0.94 Bn |
| 50 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.17 Bn | -4.91 | 15.15 | 1.17 Bn |
| 51 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | -5.53 | — | 1.13 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 71.04 | 1.39 | 0.79 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.98 Bn | -15.55 | 23.59 | 0.79 Bn |
| 54 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -48.80 | — | 0.97 Bn |
| 55 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.79 | — | 0.75 Bn |
| 56 | IVA | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | 9.70 | 179.22 | 0.89 Bn |
| 57 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.98 | 9.19 | 0.67 Bn |
| 58 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | 16.28 | 0.96 | 0.63 Bn |
| 59 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -7.90 | 3.24 | 0.59 Bn |
| 60 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.65 | 5.41 | 0.52 Bn |
| 61 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -36.84 | 5.70 | 0.62 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -8.65 | 12.51 | 0.68 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | 5.29 | 1.78 | 0.41 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.13 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -17.65 | 1.91 | 0.56 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -18.90 | — | 0.57 Bn |
| 67 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.52 | 4.77 | 0.41 Bn |
| 68 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -16.03 | 349.25 | 0.44 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.69 | 32.37 | 0.32 Bn |
| 70 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -6.64 | — | 0.28 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -87.07 | 11.24 | 0.41 Bn |
| 73 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | — | — | 0.37 Bn |
| 74 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -1.18 | 1.51 | 0.16 Bn |
| 75 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.82 | 0.42 | 0.18 Bn |
| 76 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -3.30 | — | 0.32 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -5.39 | — | 0.32 Bn |
| 78 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -39.36 | — | 0.30 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.30 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.06 | — | 0.29 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -9.01 | 1.22 | 0.11 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | 0.03 | 0.01 | -10.82 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | — | — | 0.08 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.37 | 7.53 | 0.22 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.75 | 3.20 | 0.19 Bn |
| 86 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -32.50 | — | 0.21 Bn |
| 87 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -7.49 | 15.36 | 0.16 Bn |
| 88 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.26 | 106.68 | 0.14 Bn |
| 89 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -35.91 | 8.18 | 0.19 Bn |
| 90 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -7.21 | — | 0.17 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -1.53 | — | 0.14 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.41 | 8.48 | 0.18 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -44.35 | — | 0.17 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.54 | — | 0.14 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.73 | — | 0.11 Bn |
| 96 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.86 | — | 0.13 Bn |
| 97 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -1.71 | — | 0.05 Bn |
| 98 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.63 | 3.76 | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.44 | 3.25 | 0.10 Bn |
| 100 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 101 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.51 | — | 0.09 Bn |
| 102 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 1.61 | 0.06 Bn |
| 103 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -1.30 | — | 0.08 Bn |
| 104 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -6.94 | 91.29 | 0.08 Bn |
| 105 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.76 | — | 0.07 Bn |
| 106 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.14 | — | -0.01 Bn |
| 107 | CING | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.10 | — | 0.07 Bn |
| 108 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 109 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 124.51 | — | 0.04 Bn |
| 110 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -0.33 | 1.05 | 0.00 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.07 | — | 0.05 Bn |
| 112 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.26 | 0.35 | 0.05 Bn |
| 113 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.40 | 222.77 | 0.05 Bn |
| 114 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.43 | — | 0.04 Bn |
| 115 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.83 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.20 | -0.07 Bn |
| 117 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.82 | — | 0.04 Bn |
| 118 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.57 | 8.65 | 0.03 Bn |
| 119 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.61 | 2.95 | 0.02 Bn |
| 120 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.59 | — | 0.03 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 122 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.30 | 54.16 | 0.00 Bn |
| 123 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.86 | 79.16 | 0.03 Bn |
| 124 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.07 | — | 0.03 Bn |
| 125 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -137.01 | 7.75 | 0.02 Bn |
| 126 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.77 | 0.42 | 0.00 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.89 | 916.46 | 0.02 Bn |
| 128 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.75 | — | 0.02 Bn |
| 129 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.27 | 0.45 | 0.02 Bn |
| 130 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.55 | — | 0.01 Bn |
| 131 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.67 | — | 0.02 Bn |
| 132 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.47 | — | 0.02 Bn |
| 133 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 134 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.19 | 0.02 Bn |
| 135 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.37 | — | 0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.82 | — | 0.01 Bn |
| 137 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | -8.60 | -0.01 Bn |
| 138 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.95 | — | 0.00 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 140 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.79 | — | 0.01 Bn |
| 141 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.42 | — | 0.01 Bn |
| 143 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.27 | — | 0.01 Bn |
| 144 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.99 | 1,337.11 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.31 | — | 0.00 Bn |
| 146 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 147 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 148 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.25 | 116.18 | 0.00 Bn |
| 149 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 150 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 151 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.21 | 5.02 | -0.01 Bn |
| 152 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 153 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 154 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.77 | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.02 | -0.01 Bn |
| 157 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 158 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 159 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 189.86 Bn | 35.00 | 4.08 | 184.26 Bn |
| 163 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.23 Bn | -64.67 | 6.15 | 184.05 Bn |
| 164 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.92 Bn | 31.54 | 11.04 | 131.07 Bn |
| 165 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 129.58 Bn | 41.03 | 11.74 | 124.36 Bn |
| 166 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 121.07 Bn | 25.02 | 3.33 | 111.85 Bn |
| 167 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 70.16 Bn | 19.09 | 3.34 | 69.62 Bn |
| 168 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 61.01 Bn | 19.76 | 3.16 | 59.77 Bn |
| 169 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.48 Bn | 34.56 | 6.93 | 53.98 Bn |
| 170 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 51.76 Bn | 51.57 | 7.95 | 47.50 Bn |
| 171 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 50.86 Bn | 53.99 | 2.19 | 49.99 Bn |
| 172 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.46 Bn | 61.00 | 2.45 | 38.80 Bn |
| 173 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.90 Bn | 29.30 | 3.24 | 33.44 Bn |
| 174 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.76 Bn | 33.77 | 6.79 | 31.81 Bn |
| 175 | RMD | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.12 Bn | 21.74 | 5.86 | 31.65 Bn |
| 176 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.14 Bn | 15.18 | 1.46 | 29.04 Bn |
| 177 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.41 Bn | -31.32 | 24.10 | 26.25 Bn |
| 178 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.26 Bn | -17.02 | 2,312.85 | 25.26 Bn |
| 179 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 24.19 Bn | 44.03 | 7.27 | 23.75 Bn |
| 180 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.94 Bn | 27.15 | 3.63 | 21.46 Bn |
| 181 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.74 Bn | -48.05 | 1.34 | 18.85 Bn |
| 182 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.88 Bn | 22.28 | 2.22 | 18.47 Bn |
| 183 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.76 Bn | 31.98 | 5.96 | 17.64 Bn |
| 184 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.37 Bn | 32.50 | 4.02 | 17.00 Bn |
| 185 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.58 Bn | 31.92 | 4.62 | 15.95 Bn |
| 186 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.88 Bn | 11.06 | 1.91 | 15.47 Bn |
| 187 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.45 Bn | 40.58 | 4.11 | 13.84 Bn |
| 188 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.62 Bn | 57.76 | 3.22 | 13.48 Bn |
| 189 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 13.48 Bn | 585.90 | 1.21 | 11.33 Bn |
| 190 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.93 Bn | 31.27 | 7.77 | 12.70 Bn |
| 191 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.68 Bn | 79.01 | 8.43 | 12.03 Bn |
| 192 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.81 Bn | 31.31 | 2.73 | 11.74 Bn |
| 193 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.59 Bn | 19.78 | 3.37 | 9.99 Bn |
| 194 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.48 Bn | -66.51 | 17.09 | 10.36 Bn |
| 195 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -26.89 | — | 9.50 Bn |
| 196 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.19 Bn | 27.14 | 3.34 | 9.65 Bn |
| 197 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 8.08 Bn | 22.26 | 2.05 | 7.88 Bn |
| 198 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.31 Bn | 68.10 | 10.15 | 6.92 Bn |
| 199 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.47 Bn | -722.57 | 4,648.95 | 6.47 Bn |
| 200 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.46 Bn | -39.65 | 1.21 | 6.09 Bn |
| 201 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.06 Bn | 114.61 | 5.89 | 5.35 Bn |
| 202 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.05 Bn | -12.81 | 1.99 | 5.75 Bn |
| 203 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.04 Bn | -5.36 | 2.68 | 5.74 Bn |
| 204 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.88 Bn | -33.40 | 1,171.30 | 5.70 Bn |
| 205 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.57 Bn | 35.50 | 3.90 | 5.47 Bn |
| 206 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.56 Bn | 25.80 | 1.78 | 5.43 Bn |
| 207 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.34 Bn | 36.72 | 3.38 | 4.89 Bn |
| 208 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.04 Bn | -17.55 | — | 5.04 Bn |
| 209 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.69 Bn | 48.71 | 3.47 | 4.47 Bn |
| 210 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.51 Bn | 23.77 | 3.06 | 3.99 Bn |
| 211 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.30 Bn | 33.51 | 2.33 | 4.28 Bn |
| 212 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -8.17 | 1,159.80 | 4.18 Bn |
| 213 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.15 Bn | 124.23 | 1.92 | 3.85 Bn |
| 214 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.02 Bn | — | — | 3.73 Bn |
| 215 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 4.02 Bn | -288.15 | 4.87 | 3.43 Bn |
| 216 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.73 Bn | -8.11 | 31.88 | 3.03 Bn |
| 217 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.72 Bn | -46.12 | 4,742.94 | 3.72 Bn |
| 218 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.31 Bn | 120.20 | 3.10 | 2.44 Bn |
| 219 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.06 Bn | -11.33 | 593.06 | 2.54 Bn |
| 220 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.06 Bn | 17.89 | 4.58 | 2.59 Bn |
| 221 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.95 Bn | -15.66 | 6.55 | 2.24 Bn |
| 222 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.87 Bn | -8.42 | 78.13 | 2.43 Bn |
| 223 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.72 Bn | -55.35 | 40.72 | 2.71 Bn |
| 224 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -80.66 | — | 2.62 Bn |
| 225 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.58 Bn | -21.76 | 1.97 | 2.48 Bn |
| 226 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.57 Bn | -173.90 | 10.24 | 2.46 Bn |
| 227 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -6.61 | 4.76 | 2.19 Bn |
| 228 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.50 Bn | 237.06 | 4.39 | 2.33 Bn |
| 229 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | -2.25 | 0.23 | 0.62 Bn |
| 230 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -4.02 | — | 2.09 Bn |
| 231 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.24 Bn | -57.52 | 9.10 | 2.17 Bn |
| 232 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.22 Bn | 30.71 | 3.52 | 2.21 Bn |
| 233 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.21 Bn | 1.85 | 0.08 | 0.38 Bn |
| 234 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -5.00 | 2,080.81 | 2.08 Bn |
| 235 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.05 Bn | -13.79 | 2.93 | 1.61 Bn |
| 236 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | 81.24 | 6.66 | 1.88 Bn |
| 237 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.85 Bn | 28.11 | 7.04 | 1.47 Bn |
| 238 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.82 Bn | 13.47 | 2.02 | 1.50 Bn |
| 239 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.73 Bn | 29.81 | 16.80 | 1.65 Bn |
| 240 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -3.43 | 2.21 | 1.29 Bn |
| 241 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.57 Bn | 40.11 | 1.26 | 1.28 Bn |
| 242 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | -9.11 | 20.12 | 1.29 Bn |
| 243 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 13.96 | 1.54 | 1.15 Bn |
| 244 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -9.04 | — | 1.48 Bn |
| 245 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.47 Bn | 26.09 | 1.07 | 1.44 Bn |
| 246 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.47 Bn | -13.33 | 1.80 | 1.35 Bn |
| 247 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.41 Bn | -22.19 | 1.35 | 0.95 Bn |
| 248 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.38 Bn | -10.52 | 14.55 | 1.03 Bn |
| 249 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.85 | 35.91 | 1.38 Bn |
| 250 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | -28.11 | — | 1.13 Bn |
| 251 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.28 Bn | -11.13 | 3.78 | 1.00 Bn |
| 252 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.27 Bn | -175.65 | 0.77 | 1.00 Bn |
| 253 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.26 Bn | -28.92 | 3.20 | 1.15 Bn |
| 254 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.24 Bn | 11.46 | 0.79 | 1.03 Bn |
| 255 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.23 Bn | -390.17 | 2.62 | 1.16 Bn |
| 256 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.21 Bn | 13.10 | — | 1.11 Bn |
| 257 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.20 Bn | 62.19 | 3.53 | 1.02 Bn |
| 258 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 259 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.51 | 12.38 | 1.01 Bn |
| 260 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | -72.79 | — | 0.96 Bn |
| 261 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.97 Bn | 15.75 | 1.66 | 0.94 Bn |
| 262 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.19 | 2.57 | 0.48 Bn |
| 263 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | -11.04 | 106.89 | 0.88 Bn |
| 264 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | -12.00 | 7.36 | 0.70 Bn |
| 265 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.86 Bn | -10.40 | 385.54 | 0.86 Bn |
| 266 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.82 Bn | -55.97 | 3.82 | 0.67 Bn |
| 267 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.68 Bn | -44.38 | 12.98 | 0.66 Bn |
| 268 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -364,483.91 | — | 0.35 Bn |
| 269 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.62 Bn | -16.92 | 1.94 | 0.57 Bn |
| 270 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 1,189.74 | 6.16 | 0.49 Bn |
| 271 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.56 Bn | -5.16 | 11.63 | 0.32 Bn |
| 272 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -8.00 | 24.04 | 0.26 Bn |
| 273 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.54 Bn | -13.54 | 2.13 | 0.49 Bn |
| 274 | BWAY | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.54 Bn | 56.61 | 8.86 | 0.47 Bn |
| 275 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.52 Bn | -28.70 | 2.08 | 0.46 Bn |
| 276 | DDD | 3D Systems Corp | secondary | I-12 | Machinery | IG-02 | 0.52 Bn | -10.26 | 1.34 | 0.39 Bn |
| 277 | NPCE | NeuroPace Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -26.48 | 5.09 | 0.45 Bn |
| 278 | TCMD | Tactile Systems Technology Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | 20.03 | 1.42 | 0.41 Bn |
| 279 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -10.27 | 78.36 | 0.26 Bn |
| 280 | SGHT | Sight Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.45 Bn | -20.82 | 5.41 | 0.37 Bn |
| 281 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.74 | 44.84 | 0.25 Bn |
| 282 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.59 | 45.29 | 0.36 Bn |
| 283 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.44 Bn | 28.79 | 1.39 | 0.29 Bn |
| 284 | CARL | Carlsmed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.43 Bn | -11.72 | 6.73 | 0.31 Bn |
| 285 | SI | Shoulder Innovations, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -12.07 | 7.04 | 0.32 Bn |
| 286 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.47 | 9.97 | 0.39 Bn |
| 287 | OFIX | Orthofix Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.38 Bn | -8.68 | 0.46 | 0.28 Bn |
| 288 | RCEL | AVITA Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -10.70 | 2.31 | 0.33 Bn |
| 289 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | 3.93 | 0.34 | 0.13 Bn |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.31 Bn | -5.28 | 9.84 | 0.12 Bn |
| 291 | TMCI | Treace Medical Concepts, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.31 Bn | -5.47 | 1.53 | 0.27 Bn |
| 292 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.50 | 7.47 | 0.27 Bn |
| 293 | SMTI | Sanara MedTech Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -9.77 | 2.10 | 0.30 Bn |
| 294 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -10.85 | 20.65 | 0.29 Bn |
| 295 | TLSI | TriSalus Life Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.29 Bn | -5.01 | 6.52 | 0.25 Bn |
| 296 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -130.79 | 2.31 | 0.24 Bn |
| 297 | RXST | RxSight, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.27 Bn | -6.86 | 2.08 | -0.14 Bn |
| 298 | PROF | Profound Medical Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | 3.74 | 13.05 | 0.21 Bn |
| 299 | AHG | Akso Health Group | secondary | H-16 | Healthcare Providers | HG-04 | 0.24 Bn | — | 17.93 | 0.24 Bn |
| 300 | PDEX | Pro Dex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.23 Bn | 19.21 | 3.09 | 0.22 Bn |